Answers are grounded in this paper and cite their sources.
Background Data on respiratory viruses in western Saudi Arabia after the coronavirus disease 2019 (COVID-19) mitigation period are limited. We described the viruses detected, their distribution over time and by age, clinical features, pre-existing conditions, and outcomes in a hospital-based series of polymerase chain reaction (PCR)-positive episodes at King Abdulaziz University Hospital (KAUH), Jeddah. Methods We retrospectively reviewed episodes in which at least one respiratory virus was detected by real-time PCR, primarily with a multiplex panel, in nasopharyngeal specimens tested clinically between January 2021 and December 2023; testing denominators were not available. Analyses used exact tests, odds ratios (OR) with 95% confidence intervals (CI), Benjamini-Hochberg correction, and Firth logistic regression. Results We analyzed 149 PCR-positive episodes in 143 patients; no records were available for December 2021, January to September 2022, or January 2023. Median age was 9.0 months (interquartile range 3.0 to 29.0; unknown for 32 episodes). Human respiratory syncytial virus (hRSV) was detected in 40.9% and human rhinovirus/enterovirus (hRV/hEV) in 34.2% of episodes; 16.8% had co-detections. Among episodes with known age, 70.2% of those in infants younger than 6 months were hRSV-positive (q = 0.005); at least 33 of all 61 hRSV episodes occurred in this age group. hRSV and hRV/hEV proportions differed between years, including within October and November, while testing sites also changed. No association between documented symptoms and virus detection remained significant after correction. Pre-existing conditions were documented in 46.3% of episodes and were nominally less frequent with hRSV (OR 0.31, 95% CI 0.14 to 0.64), but not after correction (q = 0.057). Specimens were collected in an intensive care unit in 22.4% of episodes; 9 of 143 patients (6.3%) had a recorded death at data extraction. Conclusions In this single-center series of PCR-positive episodes, hRSV and hRV/hEV were the most frequently detected viruses, and, among episodes with known age, hRSV was concentrated in young infants, most without documented pre-existing conditions. Without testing denominators, these data describe the composition of positive detections, not incidence or seasonality; they provide local hospital reference data from before infant hRSV immunization, whose impact will require denominator-based surveillance. Clinical trial number Not applicable.
No takes yet. Share an insight, caveat, or question.
Alhamhhum et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: